1. Home
  2. ATHA vs ETS Comparison

ATHA vs ETS Comparison

Compare ATHA & ETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • ETS
  • Stock Information
  • Founded
  • ATHA 2011
  • ETS 2020
  • Country
  • ATHA United States
  • ETS United States
  • Employees
  • ATHA N/A
  • ETS N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • ETS Trucking Freight/Courier Services
  • Sector
  • ATHA Health Care
  • ETS Industrials
  • Exchange
  • ATHA Nasdaq
  • ETS Nasdaq
  • Market Cap
  • ATHA 14.8M
  • ETS 14.7M
  • IPO Year
  • ATHA 2020
  • ETS 2025
  • Fundamental
  • Price
  • ATHA $4.07
  • ETS $0.85
  • Analyst Decision
  • ATHA
  • ETS
  • Analyst Count
  • ATHA 0
  • ETS 0
  • Target Price
  • ATHA N/A
  • ETS N/A
  • AVG Volume (30 Days)
  • ATHA 47.2K
  • ETS 442.4K
  • Earning Date
  • ATHA 11-06-2025
  • ETS 01-01-0001
  • Dividend Yield
  • ATHA N/A
  • ETS N/A
  • EPS Growth
  • ATHA N/A
  • ETS N/A
  • EPS
  • ATHA N/A
  • ETS N/A
  • Revenue
  • ATHA N/A
  • ETS $2,542,395.00
  • Revenue This Year
  • ATHA N/A
  • ETS N/A
  • Revenue Next Year
  • ATHA N/A
  • ETS N/A
  • P/E Ratio
  • ATHA N/A
  • ETS N/A
  • Revenue Growth
  • ATHA N/A
  • ETS 0.74
  • 52 Week Low
  • ATHA $2.20
  • ETS $0.83
  • 52 Week High
  • ATHA $8.26
  • ETS $4.23
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 74.28
  • ETS N/A
  • Support Level
  • ATHA $4.01
  • ETS N/A
  • Resistance Level
  • ATHA $4.59
  • ETS N/A
  • Average True Range (ATR)
  • ATHA 0.30
  • ETS 0.00
  • MACD
  • ATHA -0.05
  • ETS 0.00
  • Stochastic Oscillator
  • ATHA 47.32
  • ETS 0.00

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

About ETS Elite Express Holding Inc. Class A Common Stock

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients' doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable, and innovative delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

Share on Social Networks: